0001427920-20-000001.txt : 20200108 0001427920-20-000001.hdr.sgml : 20200108 20200108100320 ACCESSION NUMBER: 0001427920-20-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191010 FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neff Jean CENTRAL INDEX KEY: 0001427920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28666 FILM NUMBER: 20514682 MAIL ADDRESS: STREET 1: C/O ABMC STREET 2: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP CENTRAL INDEX KEY: 0000896747 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141702188 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 BUSINESS PHONE: 5187588158 MAIL ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-10-10 0 0000896747 AMERICAN BIO MEDICA CORP abmc 0001427920 Neff Jean C/O ABMC 122 SMITH ROAD KINDERHOOK NY 12106 1 0 0 0 Common Shares 2019-10-10 4 A 0 23014 0.09 A 23014 D 23,014 shares were issued to Neff (representing a value of significantly less than $10,000) as compensation for her attendance at a meeting of the Company's Board of Directors held in October 2019. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed with the Commission on April 20, 2018). The volume weighted average price of the Company's common shares for the 10 days preceding the issuance was $0.0869. Jean Neff 2020-01-08